NASDAQ
No price data available for this timeframe.
Eton Pharmaceuticals, Inc. (ETON) has a free cash flow growth of 163.19% as of Friday, May 29, 2026. This represents a 30.93% increase compared to its 12-month average of 124.63%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.